Latest News for: carrier proteins

Edit

CureVac Receives Positive Validity Decision from European Patent Office in Litigation Against BioNTech SE

ACCESSWIRE 28 Mar 2025
The principle of CureVac's proprietary technology is the use of optimized mRNA as a data carrier to instruct the human body to produce its own proteins capable of fighting a broad range of diseases.
  • 1
×